Investigations demonstrate kinetic binding properties of DNA-tagged compounds in PROTACs, suggesting new insights into drug design.
The determination of kinetic binding properties of DNA-tagged compounds binding to a target protein is an important step in the development of nucleic acid-based proteolysis targeting chimeras (PROTACs). Focal molography...
No takes yet. Share an insight, caveat, or question.
Raschke et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: